trial

A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

NCTId NCT02818777
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 13 (actual)
Sponsored by University of Colorado, Denver
Primary completion 2017-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
13 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2016-10
Primary completion
2017-11
Eligibility
ALL · 40 Years · 80 Years

Interventions & indications

Drugs
Cannabidiol

Sponsors

University of Colorado, DenverLead Sponsor
Colorado Department of Public Health and EnvironmentCollaborator
GW Research LtdCollaborator

Investigators

1
Maureen A Leehey, M.D.Principal Investigator

Sites

1 total
Aurora, United States

Linked catalysts

1
A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Dis — primary completion2017-11

Facts & assertions

4 sourced
Enrollment
13
Phase
PHASE2
Primary Completion Date
2017-11
Status
COMPLETED
relationships
The graph out of here
drug
Cannabidiol
drug
lead_sponsor
University of Colorado, Denver
company
collaborator
Colorado Department of Public Health and Environment
company
GW Research Ltd
company
indication
Tremor
indication
Psychotic Disorders
indication
Marijuana Abuse
indication
investigator
Maureen A Leehey, M.D.
person